Earl Webb Henry
Technik-/Wissenschafts-/F&E-Leiter bei H2O Clinical LLC
Profil
Earl Webb Henry is currently the Director & Chief Medical Officer at Firma Clinical Research LLC and the Chief Medical Officer at H2O Clinical LLC.
He previously worked as an Independent Director at Repligen Corp., Medical Director at HHI Clinical & Statistical Research Services LLC, Senior Associate Director-Clinical Research at Pfizer Central Research, SVP, Head-Clinical Research & Regulatory Affairs at Cephalon, Inc., Vice President-Clinical Research at Guilford Pharmaceuticals, Inc., and Chief Medical Officer at inVentiv Clinical Solutions LLC.
He also worked as the Head-Central Nervous System Therapeutic Area at Sandoz Research Institute.
Dr. Henry holds a doctorate degree from The University of Chicago and an undergraduate degree from the University of Illinois.
Aktive Positionen von Earl Webb Henry
Unternehmen | Position | Beginn |
---|---|---|
H2O Clinical LLC
H2O Clinical LLC Medical/Nursing ServicesHealth Services H2O Clinical LLC provides health care and social assistance. The company was founded on January 24, 2016 and is headquartered in Hunt Valley, MD. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2011 |
Firma Clinical Research LLC
Firma Clinical Research LLC Miscellaneous Commercial ServicesCommercial Services Firma Clinical Research LLC provides contract research and clinical research services to enable drug development. It offers data collection, data management, medical writing, patient recruitment, biostatistics, clinical pharmacology, clinical consulting, and patient retention services. The company is headquartered in Chicago, IL. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Earl Webb Henry
Unternehmen | Position | Ende |
---|---|---|
inVentiv Clinical Solutions LLC | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2011 |
HHI Clinical & Statistical Research Services LLC
HHI Clinical & Statistical Research Services LLC Miscellaneous Commercial ServicesCommercial Services Part of Syneos Health, Inc., HHI Clinical & Statistical Research Services LLC is a company that provides statistical analysis and data management to the pharmaceutical industry. The company is based in Baltimore, MD. HHI Clinical & Statistical Research Services was acquired by Ventiv Health, Inc. on November 22, 2004. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 |
Pfizer Central Research | Technik-/Wissenschafts-/F&E-Leiter | - |
Sandoz Research Institute | Corporate Officer/Principal | - |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Earl Webb Henry
The University of Chicago | Doctorate Degree |
University of Illinois | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
REPLIGEN CORPORATION | Health Technology |
Private Unternehmen | 8 |
---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
HHI Clinical & Statistical Research Services LLC
HHI Clinical & Statistical Research Services LLC Miscellaneous Commercial ServicesCommercial Services Part of Syneos Health, Inc., HHI Clinical & Statistical Research Services LLC is a company that provides statistical analysis and data management to the pharmaceutical industry. The company is based in Baltimore, MD. HHI Clinical & Statistical Research Services was acquired by Ventiv Health, Inc. on November 22, 2004. | Commercial Services |
Pfizer Central Research | |
inVentiv Clinical Solutions LLC | |
Sandoz Research Institute | |
H2O Clinical LLC
H2O Clinical LLC Medical/Nursing ServicesHealth Services H2O Clinical LLC provides health care and social assistance. The company was founded on January 24, 2016 and is headquartered in Hunt Valley, MD. | Health Services |
Firma Clinical Research LLC
Firma Clinical Research LLC Miscellaneous Commercial ServicesCommercial Services Firma Clinical Research LLC provides contract research and clinical research services to enable drug development. It offers data collection, data management, medical writing, patient recruitment, biostatistics, clinical pharmacology, clinical consulting, and patient retention services. The company is headquartered in Chicago, IL. | Commercial Services |